SCHEMBL5693586

SCHEMBL5693586

CCCC(N)(O)C(=O)NCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.58
MMP8 P22894 3/20 0.50
CYP2C19 P33261 3/20 0.48
EPHX2 P34913 1/20 0.48
CYP3A4 P08684 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
OPRK1 P41145 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
TSHR P16473 1/20 0.46
PPID Q08752 1/20 0.46
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
GAA P10253 2/20 0.44
LMNA P02545 1/20 0.44
RAB9A P51151 1/20 0.44
ALOX12 P18054 1/20 0.44
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5606082 1.00 RIPK1 (0.58) RIPK1MMP8CYP2C19EPHX2CYP3A4
SCHEMBL19176844 0.81 RIPK1 (0.76) RIPK1MMP8CYP2C19EPHX2CYP3A4
SCHEMBL10936611 0.80 RIPK1 (0.56) RIPK1MMP8CYP2C19EPHX2CYP3A4
SCHEMBL557055 0.79 RIPK1 (0.68) RIPK1MMP8CYP2C19EPHX2CYP3A4
SCHEMBL2746269 0.78 RIPK1 (0.67) RIPK1MMP8CYP2C19OPRK1SMN1; SMN2
SCHEMBL20363299 0.78 RIPK1 (0.67) RIPK1MMP8CYP2C19EPHX2CYP3A4
SCHEMBL16644093 0.76 RIPK1 (0.69) RIPK1MMP8CYP2C19OPRK1SMN1; SMN2
Acetic Acid SCHEMBL30910171 0.76 RIPK1 (0.64) RIPK1MMP8CYP2C19EPHX2CYP3A4
SCHEMBL10936211 0.76 RIPK1 (0.55) RIPK1MMP8CYP2C19EPHX2CYP3A4
SCHEMBL20363329 0.75 RIPK1 (0.62) RIPK1MMP8CYP2C19EPHX2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664003-A1 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2006-06-07 EP disclosed
WO-2005028454-A1 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2005-03-31 WO disclosed